Welcome to Paid Research Studies




  • Condition:   Cerebellar Ataxia
    Intervention:   Behavioral: Reach training with visual feedback
    Sponsors:   Hugo W. Moser Research Institute at Kennedy Krieger, Inc.;   National Institutes of Health (NIH);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Not yet recruiting

  • Condition:   Friedreich's Ataxia
    Intervention:  
    Sponsors:   University of Florida;   Children's Miracle Network;   National Institutes of Health (NIH);   Friedreich's Ataxia Research Alliance
    Recruiting

  • Condition:   Ataxia, Cerebellar
    Interventions:   Device: Cerebellar transcranial direct current stimulation;   Other: Locomotor training;   Device: Sham Cerebellar transcranial direct current stimulation
    Sponsor:   Universidade Federal de Pernambuco
    Not yet recruiting

  • Condition:   Spinocerebellar Ataxia
    Intervention:  
    Sponsor:   National Eye Institute (NEI)
    Recruiting

  • Condition:   Friedreich Ataxia
    Interventions:   Drug: Nicotinamide;   Drug: Placebo
    Sponsor:   RWTH Aachen University
    Not yet recruiting

  • Condition:   Friedreich Ataxia
    Interventions:   Drug: MIN-102;   Drug: Placebo
    Sponsor:   Minoryx Therapeutics, S.L.
    Recruiting

  • Condition:   Spinocerebellar Ataxia Type 2
    Interventions:   Drug: Riluzole;   Drug: Placebo
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Recruiting

  • Condition:   Spinocerebellar Ataxia
    Intervention:   Other: no intervention
    Sponsor:   Chinese University of Hong Kong
    Recruiting

  • Condition:   Spinocerebellar Ataxia Type 3
    Intervention:   Other: Specimen Collection
    Sponsors:   University of Michigan;   National Institutes of Health (NIH);   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Condition:   Ataxia
    Interventions:   Other: Kinect + Exercise Training;   Other: Exercise Training
    Sponsor:   Hacettepe University
    Recruiting

  • Conditions:   Ataxia, Cerebellar;   Multiple System Atrophy
    Interventions:   Drug: Tllsh2910;   Drug: Placebo
    Sponsor:   National Taiwan University Hospital
    Recruiting

  • Conditions:   Ataxia Telangiectasia;   Louis Bar Syndrome
    Intervention:   Drug: IB1001
    Sponsor:   IntraBio Inc
    Not yet recruiting

  • Condition:   Friedreich Ataxia
    Intervention:  
    Sponsors:   Children's Hospital of Philadelphia;   University of Florida;   University of California, Los Angeles
    Recruiting

  • Conditions:   Healthy Volunteers;   Optic Ataxia
    Interventions:   Behavioral: point targets;   Behavioral: tactile stimulation;   Behavioral: visual images
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Conditions:   Ataxia;   Spino Cerebellar Degeneration;   Spinocerebellar Ataxias
    Interventions:   Behavioral: Aerobic Training;   Behavioral: Balance Training
    Sponsor:   Columbia University
    Not yet recruiting

  • Conditions:   Friedreich Ataxia;   Neuro-Degenerative Disease
    Intervention:  
    Sponsors:   Children's Hospital of Philadelphia;   Friedreich's Ataxia Research Alliance;   University of Rochester
    Recruiting

  • Conditions:   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 6
    Intervention:   Genetic: All Participants
    Sponsors:   University of Florida;   National Ataxia Foundation;   University of California, Los Angeles
    Recruiting

  • Conditions:   Spinocerebellar Ataxias;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 10
    Interventions:   Drug: troriluzole;   Drug: Placebos
    Sponsor:   Biohaven Pharmaceuticals, Inc.
    Recruiting

  • Conditions:   Ataxia;   Spino Cerebellar Degeneration;   Spinocerebellar Ataxias
    Interventions:   Behavioral: Aerobic training;   Behavioral: Balance Training
    Sponsor:   Columbia University
    Recruiting

  • Conditions:   Essential Tremor;   Deep Brain Stimulation;   Ataxia;   Cerebellar Diseases
    Intervention:   Other: No intervention
    Sponsors:   Oregon Health and Science University;   Portland VA Medical Center
    Recruiting

  • Condition:   SCA7
    Interventions:   Drug: Riluzole;   Drug: Placebo
    Sponsor:   S. Andrea Hospital
    Not yet recruiting

  • Conditions:   Nervous System Disease;   Genetic Syndrome
    Interventions:   Drug: EDS-EP dose range of ~5-10 mg DSP/infusion;   Drug: EDS-EP dose range of ~14-22 mg DSP/infusion;   Drug: Placebo
    Sponsor:   Erydel
    Recruiting

  • Conditions:   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia 3
    Intervention:  
    Sponsors:   Tetsuo Ashizawa, MD;   University of Michigan;   University of Minnesota - Clinical and Translational Science Institute;   University of Utah;   University of California, Los Angeles;   University of Chicago;   University of South Florida;   Harvard University;   Johns Hopkins University;   University of Florida;   Columbia University;   Emory University;   University of California, San Francisco;   University of Alabama at Birmingham;   University of Colorado, Denver;   University of Rochester;   Stanford University;   Northwestern University;   German Center for Neurodegenerative Diseases (DZNE);   Institut de Recherche sur la Moelle épinière et l'Encéphale
    Recruiting

  • Condition:   Amyotrophic Lateral Sclerosis
    Intervention:  
    Sponsor:   Jose Luis Urcelay Segura
    Recruiting

  • Conditions:   Hypertension;   FXTAS
    Intervention:   Device: HRV and respiratory coherence biofeedback
    Sponsors:   University of California, Davis;   UC Davis MIND Institute;   UC Davis, Mini-Grant Geriatrics
    Recruiting

  • Conditions:   Traumatic Brain Injury;   Weakness, Muscle;   Coordination Impairment
    Interventions:   Behavioral: Hand coordination and mental practice;   Behavioral: Hand coordination and action observation
    Sponsor:   Kessler Foundation
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
    Intervention:   Drug: dantrolene sodium
    Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Stroke;   Spinocerebellar Ataxia;   Cerebral Stroke;   Dysphagia;   Dysarthria
    Interventions:   Device: Intermittent Perturbation to Continuous Perturbation;   Device: Continuous Perturbation to Intermittent Perturbation
    Sponsors:   University of Florida;   National Institute on Deafness and Other Communication Disorders (NIDCD);   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease;   Alagille Syndrome;   Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);   Lowe Syndrome;   Pitt Hopkins Syndrome;   1p36 Deletion Syndrome;   Jansen Type Metaphyseal Chondrodysplasia;   Cockayne Syndrome;   Chronic Recurrent Multifocal Osteomyelitis;   CRMO;   Malan Syndrome;   Hereditary Sensory and Autonomic Neuropathy Type Ie
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Conditions:   Neuropathy;   Ataxia;   Proprioceptive Disorders;   Balance; Distorted
    Interventions:   Other: Balance rehabilitation with modified visual input;   Other: Balance rehabilitation with no modified visual input
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting

  • Condition:   Developmental Coordination Disorder
    Intervention:   Device: Transcranial direct current stimulation (tDCS)
    Sponsor:   University of Sao Paulo General Hospital
    Recruiting

  • Conditions:   Leukoencephalopathies;   LBSL;   Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation;   White Matter Disease;   Ataxia, Cerebellar;   Genetic Disease
    Intervention:  
    Sponsor:   Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
    Recruiting

  • Conditions:   Ataxia;   Dystonia;   Parkinson's Disease;   Amyotrophic Lateral Sclerosis;   Corticobasal Degeneration;   Multiple System Atrophy;   Alzheimer's Disease;   Lewy Body Dementia;   Parkinson Disease-Dementia;   Dentatorubral-pallidoluysian Atrophy;   Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;   Fragile X-associated Tremor/Ataxia Syndrome;   Krabbe's Disease;   Niemann-Pick Disease, Type C;   Neuronal Ceroid Lipofuscinosis
    Intervention:  
    Sponsor:   National Institute on Aging (NIA)
    Recruiting

  • Conditions:   Parkinson Disease;   Stroke;   Multiple Sclerosis;   Gait Disorders, Neurologic;   Gait Disorder, Sensorimotor;   Gait, Unsteady;   Gait Ataxia;   Gait, Stumbling;   Gait, Shuffling
    Interventions:   Other: Feedback-assisted physical therapy;   Other: Traditional physical therapy
    Sponsors:   Oregon Health and Science University;   NorthWest Rehabilitations Associates;   APDM
    Not yet recruiting

  • Condition:   Developmental Coordination Disorder
    Interventions:   Behavioral: Rhythmical auditory stimulation gait training and muscle power training (RAS-MPT);   Behavioral: Rhythmical auditory stimulation gait training (RAS);   Behavioral: Muscle power training (MPT);   Other: Controls
    Sponsor:   The University of Hong Kong
    Not yet recruiting

  • Condition:   Developmental Coordination Disorder
    Interventions:   Behavioral: TC-MPT;   Behavioral: TC;   Behavioral: MPT
    Sponsor:   The University of Hong Kong
    Not yet recruiting

  • Conditions:   Glut1 Deficiency Syndrome;   De Vivo Disease;   Seizures;   Movement Disorders;   Intellectual Disability;   Ataxia
    Intervention:   Diagnostic Test: METAglut1
    Sponsors:   METAFORA biosystems;   European Commission;   Assistance Publique - Hôpitaux de Paris;   Cemka-Eval;   Ministry for Health and Solidarity, France;   French National Authority for Health
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
    Intervention:  
    Sponsors:   Washington University School of Medicine;   American Diabetes Association;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Recurrent Glioblastoma Multiforme;   Primary Glioblastoma Multiforme;   Brain Neoplasms, Malignant;   Leptomeningeal Disease (LMD)
    Interventions:   Radiation: Radiation Therapy;   Drug: AZD1390
    Sponsor:   AstraZeneca
    Recruiting

  • Condition:   Non Invasive Prenatal Diagnosis
    Intervention:   Genetic: Non invasive prenatal diagnosis
    Sponsor:   University Hospital, Montpellier
    Recruiting

  • Condition:   Movement Disorder
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Motor Neuron Disease;   Muscular Disease;   Muscular Dystrophy;   Peripheral Nervous System Disease
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Pancreas Cancer;   Peutz-Jeghers Syndrome (PJS);   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
    Intervention:   Drug: Human synthetic secretin
    Sponsors:   Johns Hopkins University;   ChiRhoClin, Inc.;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Cancer;   Lymphoma;   Pancreatic Cancer;   Glioblastoma Multiforme;   Sarcoma;   Breast Cancer;   Bladder Cancer;   Renal Cancer;   Ovarian Cancer;   Refractory Cancer;   Refractory Neoplasm;   Refractory Non-Hodgkin Lymphoma;   Refractory Brain Tumor;   Pancreatic Adenocarcinoma;   Resistant Cancer;   Neoplasm Metastasis;   Neoplasm of Bone;   Neoplasm, Breast;   Neoplasm of Lung;   Neoplasms,Colorectal;   Neoplasms Pancreatic;   Malignant Glioma;   Malignancies;   Malignancies Multiple;   Bone Metastases;   Bone Neoplasm;   Bone Cancer;   Pancreas Cancer;   Pancreatic Neoplasms;   Breast Neoplasms
    Interventions:   Drug: 9-ING-41;   Drug: Gemcitabine - 21 day cycle;   Drug: Doxorubicin.;   Drug: Lomustine;   Drug: Carboplatin.;   Drug: Nab paclitaxel.;   Drug: Paclitaxel.;   Drug: Gemcitabine - 28 day cycle
    Sponsors:   Actuate Therapeutics Inc.;   Developmental Therapeutics Consortium
    Recruiting